Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam.

Zhou Y, Messier N, Ouellette M, Rosen BP, Mukhopadhyay R. Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam. J Biol Chem. 2004 Sep 03; 279(36):37445-51.

View in: PubMed

authors with profiles

Barry Rosen

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support